Compass Pathways CEO on mushroom-based therapy for depression: 'The data was breathtaking'

George Goldsmith, Compass Pathways co-founder and CEO, joins 'Closing Bell' to discuss why its shares are down more than 20 percent despite positive data on its therapeutic treatment for depression.